EUCTR2006-003164-62-GB进行中（未招募）1 期
Metabolic Support with Perhexilene to Protect Myocardium undergoing Coronary Artery Surgery
niversity Hospital Birmingham0 个研究点目标入组 300 人开始时间: 2006年10月16日最近更新:
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 300
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
入选标准
- •Adult non-diabetic patients undergoing first time coronary artery bypass surgery
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •Pregnancy, renal impairment (serum creatinine> 200µmol/L), diabetes mellitus, procedures involving other heart valves and surgery for catastrophic event.
研究者
相似试验
已完成
2 期
Metabolic Support With Perhexiline to Protect Myocardium Undergoing Coronary Artery SurgeryMyocardial Reperfusion InjuryCardiac Output, LowNCT00845364University Hospital Birmingham290
进行中（未招募）
1 期
Myocardial protection with Perhexiline in Left Ventricular Hypertrophy - Perhexiline in LVHPatients with left ventricular hypertrophy undergoing aortic valve surgery (with or without coronary artery surgery)EUCTR2008-002376-95-GBniversity Hospital Birmingham NHS Foundation Trust220
已完成
2 期
Perhexiline Therapy in Patients With Hypertrophic CardiomyopathyHypertrophic CardiomyopathyNCT00500552University Hospital Birmingham44
进行中（未招募）
不适用
Perhexiline therapy in patients with Hypertrophic CardiomyopathyHypertrophic CardiomyopathyEUCTR2005-000755-15-GBniversity Hospital of Birmingham Foundation Trust50
已完成
1 期
GSK1278863 Effects on Eccentric Exercise-Induced Muscle DamageTendon InjuriesNCT02231190GlaxoSmithKline26